Semaglutide, often known as Ozempic or Wegovy, shows promise beyond diabetes and weight loss, potentially aiding in healthcare areas such as addiction and dementia.
Regular use of semaglutide improves blood sugar control for type 2 diabetes patients, with studies demonstrating its efficacy, although some trials are industry-funded.
Semaglutide aids significant weight loss in overweight individuals, becoming a potential tool in managing the obesity crisis; however, it doesn't address the underlying causes.
[
add
]
[
|
|
...
]